The present paper reports findings from a series of qualitative interviews and focus groups we conducted with different research actors. This qualitative work was part of the broader project Re-SInC (Rethinking Success, Integrity, and Culture in science; the initial workplan is available at our preregistration [35]).

In Re-SInC, we captured the views of different research actors on scientific success, problems in science, and responsibilities for integrity. Being aware that the term ‘research actor’ may be ambiguous, we defined research actors as any person having a role in the setup, funding, execution, organisation, evaluation, and/or publication of research. In other words, we included actors linked to the policing, the funding, the evaluation, the regulation, the publishing, the production (i.e., undertaking the research itself), and the practical work of research, but we did not include sole consumers of science or end users of new technologies.

We used Flanders as a setting, including participants who either participate in, influence, or reflect (directly or indirectly) upon the Flemish research scene. We will discuss below that our findings are also highly coherent with similar works in different research settings (see for example [21] in Croatia, [23] in Denmark, [28] in the US, and [3638] in the UK). In most cases (49 out of 56 participants), participants did not know the interviewer before the interviews and focus groups. In selecting participants, we aimed to capture the breadth of the Flemish research scene. Using Flanders as a research setting had the advantage of allowing us to capture perspectives from an entire research system in a feasible setting. The Flemish research scene comprises of five main universities and a number of external research institutes, major funding agencies, a federal research policy department, and one advisory integrity office external to research institutions. We chose to concentrate our research on three of the five universities, and to include partnering European funding and policy organisations as well as international journals and publisher to build a realistic system sample. When participants were affiliated with a university, we focused on the faculty of biomedical sciences. Given the exploratory and qualitative nature of this project, we did not aim for an exhaustive nor a fully representative sample. Our objective was to shift the focus from the narrow view targeting mainly researchers to a broader view that includes a broad range of research actors. Accordingly, we maximized the diversity of participants in each actor group to ensure that each group encompassed a wide range of potentially different perspectives.

Our main actor categories are PhD students, post-doctoral researchers (PostDoc), faculty researchers (Researchers), laboratory technicians (LT), policy makers and influencer (PMI), funding agencies (FA), research institution leaders (RIL), research integrity office members (RIO), editors and publishers (EP), research integrity network members (RIN), and researchers who changed career (RCC). The composition of each actor group is detailed in Table 1.

Demographics of participants

aSquare bullets (■) represent female participants; triangle bullets (▲) represent male participants, and round bullets (⬤) represent participants with undefined gender (‘prefer not to answer’). Bullets displayed in brackets represent participants with whom we conducted as focus groups or joint interviews

It is important to keep in mind that the research world is complex and not organized in distinct actor groups. Consequently, participants could often fit in more than one category, and sometimes felt the need to justify circumstances that would make them fit in the category we selected. Before the interview, we asked participants whether they agreed with the category we assigned them in, and we refined and exemplified the definitions of our actor groups to reflect the participants’ distinctions (i.e., further explaining the slight differences between the groups planned in the registration and those used here).

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.